how fast did you lose weight on tirzepatide before and after: realistic results, timelines, and what to expect ✨ Tirzepatide patient — 6

Seufert J, Lanzinger S, Danne T et al (2022) Real-world data of 12-month adjunct sodium-glucose co-transporter-2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: improved HbA1c without diabetic ketoacidosis

It's also important to consider that more is not necessarily better when it comes to supplements for GLP-1-related constipation

In type 1 diabetes mellitus, which involves autoimmune -cell destruction, adjunctive therapy with GLP-1RA has shown promise in patients with residual -cell function

We believe this approach improves not only weight loss outcomes but also patient well-being

Consistent with findings from the OASIS 1 trial [23], only 5% of patients discontinued treatment due to gastrointestinal intolerance